These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 7540795

  • 1. [5-alpha-reductase inhibitors].
    De Jaegher K, Kozyreff P, Claes H.
    Acta Urol Belg; 1994 Dec; 62(4):23-31. PubMed ID: 7540795
    [Abstract] [Full Text] [Related]

  • 2. [Drug therapy for prostatic hyperplasia].
    Sane T.
    Duodecim; 1993 Dec; 109(20):1849-54. PubMed ID: 7537654
    [No Abstract] [Full Text] [Related]

  • 3. 5alpha-reductase inhibitors.
    Rittmaster RS.
    J Androl; 1997 Dec; 18(6):582-7. PubMed ID: 9432130
    [No Abstract] [Full Text] [Related]

  • 4. The concentrations of the endogenous C19-steroids in hyperplastic prostatic tissue and the effect of finasteride treatment.
    Hill M, Petrik R, Hampl R, Stárka L.
    Horm Metab Res; 1996 Oct; 28(10):562-4. PubMed ID: 8934217
    [Abstract] [Full Text] [Related]

  • 5. Finasteride in benign prostatic hyperplasia.
    Wysowski DK, Farinas E.
    N Engl J Med; 2004 Mar 25; 350(13):1359-61; author reply 1359-61. PubMed ID: 15044649
    [No Abstract] [Full Text] [Related]

  • 6. [The effect of 5-alpha-reductase inhibitors on benign prostatic hyperplasia].
    Djavan B, McConnell J.
    Wien Med Wochenschr; 1996 Mar 25; 146(8):165-8. PubMed ID: 8767401
    [Abstract] [Full Text] [Related]

  • 7. [Hormonal therapy for benign prostatic hyperplasia].
    Sakai H, Kanetake H.
    Nihon Rinsho; 2002 Dec 25; 60 Suppl 11():358-61. PubMed ID: 12599600
    [No Abstract] [Full Text] [Related]

  • 8. Effects of finasteride on vascular endothelial growth factor.
    Häggström S, Tørring N, Møller K, Jensen E, Lund L, Nielsen JE, Bergh A, Damber JE.
    Scand J Urol Nephrol; 2002 Dec 25; 36(3):182-7. PubMed ID: 12201932
    [Abstract] [Full Text] [Related]

  • 9. Benign prostatic hyperplasia: dihydrotestosterone and 5 alpha-reductase inhibition therapy.
    Imperato-McGinley J.
    Prog Clin Biol Res; 1994 Dec 25; 386():197-203. PubMed ID: 7528387
    [No Abstract] [Full Text] [Related]

  • 10. Finasteride: a 5 alpha-reductase inhibitor.
    Steiner JF.
    Clin Pharm; 1993 Jan 25; 12(1):15-23. PubMed ID: 7679063
    [Abstract] [Full Text] [Related]

  • 11. 5alpha-Reductase inhibitor treatment of prostatic diseases: background and practical implications.
    Dörsam J, Altwein J.
    Prostate Cancer Prostatic Dis; 2009 Jan 25; 12(2):130-6. PubMed ID: 19030020
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [5-alpha reductase inhibitors or alpha blockers? The combination brakes best prostatic hyperplasia].
    MMW Fortschr Med; 2002 Oct 31; 144(44):56. PubMed ID: 12494605
    [No Abstract] [Full Text] [Related]

  • 14. [Proscar (finasteride, MSD) in the treatment of patients with prostatic hyperplasia].
    Pytel' IuA, Vinarov AZ.
    Urol Nefrol (Mosk); 1996 Oct 31; (4):25-7. PubMed ID: 8928344
    [Abstract] [Full Text] [Related]

  • 15. [Histomorphometry study of the effect of an inhibitor of 5-alpha reductase on the coating of human prostate explants in tissue culture].
    López Muñoz A, Larrán Lopez J, Salido Peracaula M, Aparicio Patino J, Vilches Troya J.
    Actas Urol Esp; 1998 Jan 31; 22(1):11-6. PubMed ID: 9580265
    [Abstract] [Full Text] [Related]

  • 16. [Influence of dihydrotestosterone deficit on treatment of prostatic diseases regarding to contemporary methods of prostatic hypertrophy treatments].
    Laszczyńska M, Chorzepa-Nowicka K, Wylot M, Piasecka M, Gaczarzewicz D.
    Pol Merkur Lekarski; 2008 Dec 31; 25(150):528-30. PubMed ID: 19205388
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of men on finasteride.
    Gormley GJ.
    Semin Urol Oncol; 1996 Aug 31; 14(3):139-44. PubMed ID: 8865475
    [Abstract] [Full Text] [Related]

  • 18. Finasteride to prevent morbidity from benign prostatic hyperplasia.
    Wasson JH.
    N Engl J Med; 1998 Feb 26; 338(9):612-3. PubMed ID: 9475770
    [No Abstract] [Full Text] [Related]

  • 19. Finasteride in benign prostatic hyperplasia.
    Verhamme KM, Bosch RJ, Sturkenboom MC.
    N Engl J Med; 2004 Mar 25; 350(13):1359-61; author reply 1359-61. PubMed ID: 15049034
    [No Abstract] [Full Text] [Related]

  • 20. Finasteride in the treatment of patients with moderate symptoms of benign prostatic hyperplasia.
    Magoha GA.
    East Afr Med J; 1998 May 25; 75(5):260-3. PubMed ID: 9746993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.